Search research articles
Contact Us
Filters
Showing results (741-750 of 1,104) with videos related to
Page
of 111
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 16, 2002
Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate
Christos N Papandreou, Danai D Daliani, Peter F Thall, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 29, 2021
Enhancing <sup>223</sup>Ra Treatment Efficacy by Anti-<b>β</b>1 Integrin Targeting
Claudia Paindelli, Stefano Casarin, Feng Wang, et al.
ACS Nano
|
December 14, 2017
Exploring the Nanotoxicology of MoS<sub>2</sub>: A Study on the Interaction of MoS<sub>2</sub> Nanoflakes and K<sup>+</sup> Channels
Zonglin Gu, Leigh D Plant, Xuan-Yu Meng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2003
Randomized, multicenter, phase II trial of two multicomponent regimens in androgen-independent prostate cancer
Randall Millikan, Peter F Thall, Sang-Joon Lee, et al.
Carcinogenesis
|
August 13, 2016
Genetic variants of the Wnt signaling pathway as predictors of aggressive disease and reclassification in men with early stage prostate cancer on active surveillance
Xiang Shu, Yuanqing Ye, Jian Gu, et al.
Molecular Pain
|
August 13, 2009
Subtype-specific regulation of P2X3 and P2X2/3 receptors by phosphoinositides in peripheral nociceptors
Gary Mo, Louis-Philippe Bernier, Qi Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2002
Phase III trial of fluorouracil, interferon alpha-2b, and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in metastatic or unresectable urothelial cancer
Arlene O Siefker-Radtke, Randall E Millikan, Shi-Ming Tu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 15, 2012
PIP2 controls voltage-sensor movement and pore opening of Kv channels through the S4-S5 linker
Aldo A Rodriguez-Menchaca, Scott K Adney, Qiong-Yao Tang, et al.
The Prostate
|
July 4, 2012
Integrated Hedgehog signaling is induced following castration in human and murine prostate cancers
Eleni Efstathiou, Maria Karlou, Sijin Wen, et al.
Anticancer Research
|
November 3, 2004
High efficacy of docetaxel with and without androgen deprivation and estramustine in preclinical models of advanced prostate cancer
Karim Fizazi, Charles R Sikes, Jeri Kim, et al.
Page
of 111
Search research articles
Search
Showing results (741-750 of 1,104) with videos related to
Sort By:
Page
of 111
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 16, 2002
Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate
Christos N Papandreou, Danai D Daliani, Peter F Thall, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 29, 2021
Enhancing <sup>223</sup>Ra Treatment Efficacy by Anti-<b>β</b>1 Integrin Targeting
Claudia Paindelli, Stefano Casarin, Feng Wang, et al.
ACS Nano
|
December 14, 2017
Exploring the Nanotoxicology of MoS<sub>2</sub>: A Study on the Interaction of MoS<sub>2</sub> Nanoflakes and K<sup>+</sup> Channels
Zonglin Gu, Leigh D Plant, Xuan-Yu Meng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2003
Randomized, multicenter, phase II trial of two multicomponent regimens in androgen-independent prostate cancer
Randall Millikan, Peter F Thall, Sang-Joon Lee, et al.
Carcinogenesis
|
August 13, 2016
Genetic variants of the Wnt signaling pathway as predictors of aggressive disease and reclassification in men with early stage prostate cancer on active surveillance
Xiang Shu, Yuanqing Ye, Jian Gu, et al.
Molecular Pain
|
August 13, 2009
Subtype-specific regulation of P2X3 and P2X2/3 receptors by phosphoinositides in peripheral nociceptors
Gary Mo, Louis-Philippe Bernier, Qi Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2002
Phase III trial of fluorouracil, interferon alpha-2b, and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in metastatic or unresectable urothelial cancer
Arlene O Siefker-Radtke, Randall E Millikan, Shi-Ming Tu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 15, 2012
PIP2 controls voltage-sensor movement and pore opening of Kv channels through the S4-S5 linker
Aldo A Rodriguez-Menchaca, Scott K Adney, Qiong-Yao Tang, et al.
The Prostate
|
July 4, 2012
Integrated Hedgehog signaling is induced following castration in human and murine prostate cancers
Eleni Efstathiou, Maria Karlou, Sijin Wen, et al.
Anticancer Research
|
November 3, 2004
High efficacy of docetaxel with and without androgen deprivation and estramustine in preclinical models of advanced prostate cancer
Karim Fizazi, Charles R Sikes, Jeri Kim, et al.
Page
of 111